Peregrine announces 2010 Q2 results

Peregrine Pharmaceuticals has reported its second-quarter 2010 financial results.

source : www.auntminnie.com

Related News:

• Medicis Announces Approval Of Additional Strengths Of Solodyn(R)
• CareFusion Announces National Launch Of Spinal Fracture Device
• BrainScope(TM) Announces Findings Of Traumatic Brain Injury Study In The Emergency Department
• Melanoma Research Alliance Announces $5.2 Million In New Grants To Support Six Innovative Multidisciplinary Research Programs
• Zimmer Announces First Implantation Of NCB(R) Periprosthetic Plating System
• Amgen Announces Top-Line Results Of Phase 3 Head And Neck Cancer Trial
• Boston Scientific Announces FDA Approval Of New Leads For The Precision Plus™ Spinal Cord Stimulator System
• Topaz Pharmaceuticals Announces Positive Data From Topical Ivermectin Trials Presented At Society Of Pediatric Dermatology
• CMS Announces New Prospective Payment System For End-Stage Renal Disease Facilities
• NPS Pharmaceuticals Announces Completion Of Patient Randomization In Phase 3 STEPS Study Of GATTEX(R) In Short Bowel Syndrome

Details :
Submited at Thursday, December 10th, 2009 at 7:00 pm on Radiology by robert
Comment RSS 2.0 - leave a comment - trackback